Tech Company Financing Transactions

SciRhom Funding Round

SciRhom closed a $68 million Series A funding round on 7/9/2024. Backers included Andera Partners, Hadean Ventures and Kurma Partners.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Life Sciences

Mailing Address

Am Klopferspitz 19
Martinsried, 82152
Germany

Phone

+49-89-6142412 36

Website

www.scirhom.com

Email Address

[email protected]

Overview

SciRhom GmbH is a pioneering biotech enterprise with the vision to translate advanced scientific findings into game-changing therapies for autoimmune diseases. Building on a detailed understanding of how a major cell-surface protease controls inflammation, SciRhom has worked closely with Prof. Carl Blobel of the Hospital for Special Surgery in New York City (USA) to develop first-in-class humanized antibodies against iRhom2.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jan Poth

        

Chief Executive Officer

Jens Ruhe

        

Chief Medical Officer

Jürgen Reeß

        

Chief Scientific Officer

Matthias Schneider

        

Browse more venture capital transactions:

Prev: 7/9/2024: Courier Health venture capital transaction
Next: 7/9/2024: NodaFi venture capital transaction

Share this article

About Database of VC Transactions

We report on every notable VC transaction. VC investment data records reported here are derived from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary